In patients with SSc, the expression of the two markers was significantly higher than that in the other three groups: CD57 expression in CD4+/CD57+ T cells (Supplementary Figure 5) and CD16 expression in NK cells (Supplementary Figure 9). The gene discussed is B3GAT1; the disease is systemic sclerosis.